MedTech T2S Group Holding, the leading medical technology group in Morocco and across more than twenty African countries, has received authorization from the Moroccan Capital Market Authority (AMMC) for its planned initial public offering (IPO) on the Casablanca Stock Exchange, seeking to raise nearly 1.09 billion dirhams to support its next phase of growth.
The transaction combines a capital increase of approximately 350 million dirhams and the sale of existing shares worth around 750 million dirhams, the company said in a prospectus.
Shares will be offered at 223 dirhams each, with the subscription period scheduled from July 13 to July 17, 2026.
Founded in 1992, T2S Group has become one of Morocco’s leading MedTech players, supplying hospitals, laboratories and radiology centers with advanced medical equipment, diagnostics solutions and healthcare technology services.
The company also operates in radiopharmaceutical production through its Cyclopharma subsidiary and is developing artificial intelligence solutions for medical imaging.
The company said the IPO proceeds will be used to strengthen its core activities, launch new product lines, expand across African markets and pursue external growth opportunities through acquisitions.
